Comment on

• Efficacy and safety of baricitinib in combination with topical corticosteroids in paediatric patients with moderate-to-severe atopic dermatitis with an inadequate response to topical corticosteroids: results from a phase III, randomized, double-blind, placebo-controlled study (BREEZE-AD PEDS).

  Torrelo A, Rewerska B, Galimberti M, Paller A, Yang CY, Prakash A, Zhu D, Pontes Filho MAG, Wu WS, Eichenfield LF. Torrelo A, et al. Br J Dermatol. 2023 Jul 7;189(1):23-32. doi: 10.1093/bjd/ljad096. Br J Dermatol. 2023. PMID: 36999560 Clinical Trial.